Effect of Remimazolam- Vs Propofol-Based Intravenous Anesthesia on Surgical Stress Response and Post-Operative Immune Function in Patients with Gastric Radical Surgery
Qingqing Xu,Xue Cheng,Hong Sun,Guangyuan Su,Yuanhui Fei,Chunhui Wang,Chao Han
DOI: https://doi.org/10.2147/dddt.s489167
IF: 4.3188
2024-11-16
Drug Design Development and Therapy
Abstract:Qingqing Xu, Xue Cheng, Hong Sun, Guangyuan Su, Yuanhui Fei, Chunhui Wang, Chao Han Department of Anesthesiology, The Affiliated Yixing Hospital of Jiangsu University, Yixing, Jiangsu, People's Republic of China Correspondence: Chao Han, Department of Anesthesiology, The Affiliated Yixing Hospital of Jiangsu University, Yixing, Jiangsu, 214200, People's Republic of China, Tel +8613961568178, Email Purpose: This study aimed to compare the impact of remimazolam-based versus propofol-based intravenous anesthesia on surgical stress and post-operative immune function in patients undergoing gastric radical surgery. Patients and Methods: Sixty-eight patients aged 50 to 80 undergoing gastric radical surgery were randomly assigned to the remimazolam group (group R) or the propofol group (group P), receiving remimazolam or propofol-based intravenous anesthesia, respectively. The primary outcome measured was peri-operative serum stress indicators and lymphocyte subtypes. Secondary outcomes included hemodynamic vitals, recovery quality, postoperative pain profiles and potential adverse effects. Results: The demographic and surgical characteristics of the 60 analyzed patients were comparable. The absolute counts of CD3+CD4+ and CD3+CD8+ cell decreased significantly on POD1 compared with baseline. On POD3, the numbers of CD3+CD4+ cells in group R were lower than baseline and Group P, whereas the CD3+CD8+ cell counts in both groups were lower than baseline, with group R higher than group P. The CD3-CD16+CD56+ cell numbers in both groups on POD1 and POD3 decreased significantly compared to baseline with group P lower than group R on POD3. The serum levels of IL-1β, IL-6, TNF-α, ACTH and COR rose sharply 2 hours after the beginning of surgery compared to baseline. Notably, all these parameters in group R were higher than those in group P. Additionally, blood pressure and intra-operative vasoactive drug frequency in group R were higher than that in group P. No significant differences in recovery quality, postoperative pain profiles, and potential adverse effects were observed. Conclusion: Remimazolam-based intravenous anesthesia might favour the recovery of cellular immune function in early postoperative period compared to propofol. On the contrary, remimazolam was inferior to propofol in suppressing surgical stress. Further studies with larger sample sizes are needed to confirm our findings. Keywords: remimazolam, propofol, surgical stress, post-operative immune function, gastric radical surgery Remimazolam is a novel water-soluble, ultra-short-acting benzodiazepine (BDZ). Similar to other BDZs, remimazolam enhances γ-amino-butyric acid A (GABAA) receptor activity and increases chloride ion flux, causing membrane hyperpolarization and inhibition of neuronal activity, thereby inducing anxiolysis, amnesia, and sedation. 1 Owing to its structural soft drug design, analogous to remifentanil, incorporating a carboxylic ester moiety into the BDZ core, 1 remimazolam can be rapidly hydrolyzed to a pharmacologically inactive metabolite (CNS 7054) via non-specific tissue esterase activity. This results in its favorable pharmacological properties, including rapid onset, organ-independent metabolism, short duration of action, predictable recovery, and the availability of a reversal agent. 2,3 Despite the initial market positioning of remimazolam for outpatient non-intubation procedure sedation, 4 such as endoscopic operations, its application scope quickly expanded to include the induction and maintenance of general anesthesia as research progressed. Previous publications largely focused on the application of remimazolam in various clinical contexts, demonstrating its efficacy and safety in procedure sedation and general anesthesia 5–8 . The immunosuppressive response triggered by surgical trauma is widely regarded as a key determinant of postoperative complications, such as end-organ damage, infections, and protracted recovery. 9 Furthermore, some clinical studies suggested that postoperative immunosuppression be associated cancer recurrence and metastasis. 10 The effects of anesthetic agents on immune function have garnered increasing interest and attention in recent years. However, there are a few reports about the impact of remimazolam on surgical stress response and post-operative immune function. Therefore, the primary objective of this study was to investigate the effects of remimazolam-based intravenous anesthesia on stress response and post-operative immune function compared with propofol in patients undergoing gastric radical surgery. This prospective, randomized, controlled, single-blind study was approved by the Ethics Committee of Affiliated Yixing Hospital of Jiangsu -Abstract Truncated-
pharmacology & pharmacy,chemistry, medicinal